Answer
In 2022, Katalin Karikó left BioNTech RNA Pharmaceuticals to focus more on research. She is a Hungarian-American biochemist and molecular biologist who is known for her work on mRNA vaccines, which has been used to combat the COVID-19 pandemic. Karikó's work on mRNA vaccines began in the 1990s, when she was a researcher at the University of Pennsylvania.